YSM News and Recognition
Researchers investigate how the tobacco industry is using social media to promote vaping to teens; YSM team studies sex differences in brain bleeds; study shows increased utilization of active surveillance and watchful waiting strategies for prostate cancer.
News
- November 22, 2024
Researchers are investigating how the tobacco industry is using social media to promote vaping to teens, and they are developing interventions for deterring e-cigarette use.
- November 20, 2024
Brain bleeds in men can be more severe but their outcomes are better when compared with women's, a new Yale-led study has found.
- November 21, 2024
Yale School of Medicine teams have received three grants totaling $18 million from Aligning Science Across Parkinson’s (ASAP), a coordinated research initiative devoted to accelerating the pace of discovery and informing the path to a cure for Parkinson’s disease (PD) research.
- November 22, 2024
A new study led by Yale Cancer Center researchers at Yale School of Medicine found a substantial increase in the adoption of active surveillance (AS) and watchful waiting (WW) treatment strategies over the past decade — an encouraging trend for men seeking less-invasive treatment options.
- November 21, 2024
Jeffrey Wickersham, PhD, associate professor of medicine (infectious diseases) at Yale School of Medicine, and co-principal investigator Roman Shrestha, PhD, MPH, designed a micro-randomized trial using a just-in-time adaptive intervention to determine whether using an app could discourage HIV-uninfected gay or bisexual men from engaging in high-risk behavior that would put them at risk for HIV transmission.
- November 20, 2024
Worldwide, the population is getting older, so it’s imperative to understand the cell changes that come with age, stresses Ruth Montgomery, PhD, professor of medicine (rheumatology) and of epidemiology (microbial diseases) at Yale School of Medicine. “Older people are more susceptible to infectious diseases and less responsive to vaccines,” she said.
- November 12, 2024
Yale research published in the Journal of the American Heart Association in September 2024 illuminates the changes in care that occur when women undergo advanced testing to get to the bottom of their heart problems.
- November 20, 2024
A new diagnosis of dementia is associated with a 40 percent increase in emergency department visits within the year surrounding the diagnosis, with visit frequency peaking just before the diagnosis is made. This spike in ED visits highlights an important opportunity for healthcare providers to identify cognitive issues early and offer necessary support to patients and their caregivers.
- November 21, 2024
Researchers at the Yale School of Public Health and Yale School of Medicine, in conjunction with Equitable Breakthroughs in Medicine, a multi-institute collaboration focused on clinical trial diversity, have published a Site Maturity Assessment Model in the journal Trials. The model is designed to support clinical trial sites to identify opportunities for growth and to enrich diversity.
Recognition
Ebbs Named Yale Site Lead, Athanasopoulou To Be Education Representative for PPN
Daniel Ebbs, DO, instructor in pediatric critical care medicine, was named the Yale hub site lead for the Pediatric Pandemic Network (PPN), and Sofia Athanasopoulou, MD, clinical fellow in pediatrics, was named the Yale hub site education representative. Yale was invited to join the PPN as its 12th affiliate hub site nationwide. As part of the collaboration, Yale will work alongside other PPN sites to share expertise, resources, and innovative approaches to pediatric emergency care and disaster preparedness.
Herbst Receives Ezra Greenspan Award from The Chemotherapy Foundation
Roy Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology) and professor of pharmacology, was awarded the Ezra Greenspan award from The Chemotherapy Foundation. The award, named for the oncologist who founded the organization in 1968, was made at TCF's Innovation Gala in NYC Nov. 19. It followed its 42nd annual Chemotherapy Foundation symposium.
Jubanyik and Colucci Receive CCEP Awards
Karen Jubanyik, MD, associate professor of emergency medicine (right), was recently honored with the Phil Stent Award from the Connecticut College of Emergency Physicians (CCEP). This annual award honors an emergency physician for their dedication, leadership, and overall contribution to the field, not only to recognize leaders’ achievements and contributions, but also to provide inspiration for future generations of emergency physicians. Furthermore, Leah Colucci, MD, chief resident in the Department of Emergency Medicine (left), was recently honored with the CCEP 2024 Resident of the Year Award. This annual award recognizes residents for their excellence in patient care and education.
Kunz Honored With NANET 2024 Distinguished Mentor Award
Pamela Kunz, MD, associate professor of internal medicine (medical oncology), was honored with the Distinguished Mentor Award at the 2024 Multidisciplinary North American Neuroendocrine Tumor (NANET) Society Medical Symposium.
Merchant Wins New England Regional Meeting Award
Naseema Merchant, MD, associate professor of medicine (general medicine), received the Leader in General Internal Medicine Award at the Society of General Internal Medicine (SGIM) New England Regional Meeting. This award aims to acknowledge the achievements of mid-level and senior-level SGIM members and encourages their ongoing engagement and contributions to the regional SGIM.
Sansing Awarded AHA Basic Research Prize
Lauren Hachmann Sansing, MD, professor of neurology and vice chair of faculty affairs, received the Basic Research Prize at the presidential awards ceremony at the American Heart Association Scientific Sessions 2024. The AHA Scientific Council Awards applaud the achievements of researchers, scientists, clinicians, nurses, and allied health professionals, and provide opportunities for financial rewards, special presentations, and funding to attend the AHA Scientific Sessions and other council-sponsored meetings.